{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:05:29Z","timestamp":1791471929859,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373912"],"award-info":[{"award-number":["82373912"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430118"],"award-info":[{"award-number":["82430118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300685"],"award-info":[{"award-number":["82300685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFD1601400"],"award-info":[{"award-number":["2023YFD1601400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002857","name":"China Pharmaceutical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Jiangsu Province Natural Science Foundation","doi-asserted-by":"publisher","award":["BK20221052"],"award-info":[{"award-number":["BK20221052"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117200","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:47:59Z","timestamp":1753890479000},"page":"117200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Nodosin alleviates cholestatic liver injury by activation of SIRT1\/FXR signaling pathway and inhibition of hepatic inflammation"],"prefix":"10.1016","volume":"242","author":[{"given":"Mingzhu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtao","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9366-7151","authenticated-orcid":false,"given":"Hao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0005","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1053\/j.gastro.2010.09.004","article-title":"Pathogenesis of cholestatic liver disease and therapeutic approaches","volume":"139","author":"Hirschfield","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1089-3261(03)00128-4","article-title":"An approach to the management of the pruritus of cholestasis","volume":"8","author":"Bergasa","year":"2004","journal-title":"Clin. Liver Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117200_b0015","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0004563218817798","article-title":"Bile acids and the metabolic syndrome","volume":"56","author":"McGlone","year":"2019","journal-title":"Ann. Clin. Biochem."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jceh.2021.08.017","article-title":"A current understanding of bile acids in chronic liver disease","volume":"12","author":"Farooqui","year":"2022","journal-title":"J. Clin. Experim. Hepatol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0025","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/hep.32289","article-title":"Loss of bile salt export pump aggravates lipopolysaccharide\u2010induced liver injury in mice due to impaired hepatic endotoxin clearance","volume":"75","author":"Remetic","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","article-title":"Bile Acids Induce Inflammatory Genes in Hepatocytes","volume":"178","author":"Allen","year":"2011","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0035","doi-asserted-by":"crossref","first-page":"e0020","DOI":"10.1097\/HC9.0000000000000020","article-title":"Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injury","volume":"7","author":"Shearn","year":"2023","journal-title":"Hepatology Communications"},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0040","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/gutjnl-2021-324305","article-title":"Novel therapeutic targets for cholestatic and fatty liver disease","volume":"71","author":"Trauner","year":"2022","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2025.117200_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2021.100941","article-title":"Nuclear receptors, gestational metabolism and maternal metabolic disorders","volume":"78","author":"Manna","year":"2021","journal-title":"Mol. Aspects Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117200_b0050","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1203\/PDR.0b013e318170a6b5","article-title":"Expression of hepatocyte transporters and nuclear receptors in children with early and late-stage biliary atresia","volume":"63","author":"Chen","year":"2008","journal-title":"Pediatr. Res."},{"issue":"17","key":"10.1016\/j.bcp.2025.117200_b0055","doi-asserted-by":"crossref","first-page":"13494","DOI":"10.3390\/ijms241713494","article-title":"FXR Maintains the Intestinal Barrier and Stemness by Regulating CYP11A1-Mediated Corticosterone Synthesis in Biliary Obstruction Diseases","volume":"24","author":"Li","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0060","doi-asserted-by":"crossref","first-page":"39573","DOI":"10.1038\/srep39573","article-title":"Impaired Hepatic Adaptation to Chronic Cholestasis induced by Primary Sclerosing Cholangitis","volume":"6","author":"Milkiewicz","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0065","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2009.09.009","article-title":"FXR Acetylation is Normally Dynamically Regulated by p300 and SIRT1 but Constitutively Elevated in Metabolic Disease States","volume":"10","author":"Kemper","year":"2009","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/abbs\/gms108","article-title":"SIRT1 and energy metabolism","volume":"45","author":"Li","year":"2013","journal-title":"Acta Biochim. Biophy. Sin."},{"key":"10.1016\/j.bcp.2025.117200_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106386","article-title":"Sirtuin 1 activation alleviates primary biliary cholangitis via the blocking of the NF-\u03baB signaling pathway","volume":"83","author":"Li","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0080","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","article-title":"Role of Silent Information Regulator 1 (SIRT1) in Regulating Oxidative stress and Inflammation","volume":"43","author":"Singh","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.bcp.2025.117200_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154971","article-title":"Geniposide alleviated bile acid-associated NLRP3 inflammasome activation by regulating SIRT1\/FXR signaling in bile duct ligation-induced liver fibrosis","volume":"118","author":"Qin","year":"2023","journal-title":"Phytomedicine"},{"issue":"6","key":"10.1016\/j.bcp.2025.117200_b0090","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/hep.28826","article-title":"Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid\u2013fed mouse model of cholestasis","volume":"64","author":"Kulkarni","year":"2016","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.bcp.2025.117200_b0095","first-page":"195","article-title":"Progress in approved drugs from natural product resources","volume":"22","author":"Luo","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0100","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1142\/S0192415X10007713","article-title":"Anti-inflammatory function of Nodosin via inhibition of IL-2","volume":"38","author":"Li","year":"2010","journal-title":"Am. J. Chin. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117200_b0105","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70049","article-title":"Anti\u2010Proliferation effect of Nodosin on Hepatocellular Carcinoma Cells Via the ERCC6L\/PI3K\/AKT\/Axis","volume":"38","author":"Wang","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117200_b0110","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1440-1746.2011.06966.x","article-title":"Preconditioning donor liver with Nodosin perfusion lessens rat ischemia reperfusion injury via heme oxygenase\u20101 upregulation","volume":"27","author":"Wang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"43","key":"10.1016\/j.bcp.2025.117200_b0115","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1016\/j.chroma.2011.08.033","article-title":"A sensitive analysis method for 7 diterpenoids in rat plasma by liquid chromatography\u2013electrospray ionization mass spectrometry and its application to pharmacokinetic study of Isodon serra extract","volume":"1218","author":"Du","year":"2011","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.bcp.2025.117200_b0120","first-page":"1","article-title":"Isodons A-H, seco-abietane and abietane-type diterpenoids from Isodon lophanthoides: isolation, structural elucidation, and anticholestatic activity","volume":"22","author":"Zhou","year":"2024","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.bcp.2025.117200_b0125","doi-asserted-by":"crossref","unstructured":"H. Can Sakarya, A. Ketrez, Synthesis of Novel cis-2-Azetidinones from imines and aclychloride using triethylamine, Acta chimica Slovenica 70(4) (2023) 628-633, doi: 10.17344\/acsi.2023.8451.","DOI":"10.17344\/acsi.2023.8451"},{"issue":"9","key":"10.1016\/j.bcp.2025.117200_b0130","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","article-title":"The cellular thermal shift assay for evaluating drug target interactions in cells","volume":"9","author":"Jafari","year":"2014","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bcp.2025.117200_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114798","article-title":"Drug affinity responsive target stability (DARTS) accelerated small molecules target discovery: Principles and application","volume":"194","author":"Ren","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117200_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7007","key":"10.1016\/j.bcp.2025.117200_b0145","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature02924","article-title":"NF-\u03baB functions as a tumour promoter in inflammation-associated cancer","volume":"431","author":"Pikarsky","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.117200_b0150","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.toxlet.2021.05.012","article-title":"The inhibition of NF\u043aB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity","volume":"349","author":"Ahmadi","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0155","doi-asserted-by":"crossref","first-page":"12407","DOI":"10.1111\/jpi.12407","article-title":"Melatonin reverses H(2) O(2) -induced senescence in SH-SY5Y cells by enhancing autophagy via sirtuin 1 deacetylation of the RelA\/p65 subunit of NF-\u03baB","volume":"63","author":"Nopparat","year":"2017","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2025.117200_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172392","article-title":"SIRT1 alleviates Cd nephrotoxicity through NF-\u03baB\/p65 deacetylation-mediated pyroptosis in rat renal tubular epithelial cells","volume":"929","author":"Dong","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.bcp.2025.117200_b0165","doi-asserted-by":"crossref","unstructured":"L. Chen, W. Fischle, E. Verdin, W.C. Greene, Duration of nuclear NF-kappaB action regulated by reversible acetylation, Science (New York, N.Y.) 293(5535) (2001) 1653-7, doi: 10.1126\/science.1062374.","DOI":"10.1126\/science.1062374"},{"issue":"20","key":"10.1016\/j.bcp.2025.117200_b0170","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1128\/MCB.21.20.7065-7077.2001","article-title":"The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression","volume":"21","author":"Ashburner","year":"2001","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117200_b0175","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1074\/jbc.M209572200","article-title":"Post-activation turn-off of NF-kappa B-dependent transcription is regulated by acetylation of p65","volume":"278","author":"Kiernan","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0180","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.22519","article-title":"Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response","volume":"48","author":"Wang","year":"2008","journal-title":"Hepatology"},{"issue":"Pt 1","key":"10.1016\/j.bcp.2025.117200_b0185","article-title":"Ursodeoxycholic acid alleviates fat embolism syndrome-induced acute lung injury by inhibiting the p38 MAPK\/NF-\u03baB signalling pathway through FXR","volume":"230","author":"He","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117200_b0190","first-page":"384","article-title":"Effective compounds screening from Rabdosia serra (Maxim) Hara against HBV and tumor in vitro","volume":"7","author":"Chen","year":"2014","journal-title":"Int. J. Clin. Exp. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117200_b0195","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jpha.2022.08.001","article-title":"Rabdosia serra alleviates dextran sulfate sodium salt-induced colitis in mice through anti-inflammation, regulating Th17\/Treg balance, maintaining intestinal barrier integrity, and modulating gut microbiota","volume":"12","author":"Li","year":"2022","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bcp.2025.117200_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153683","article-title":"A UPLC-MS\/MS-based metabolomics analysis of the pharmacological mechanisms of rabdosia serra against cholestasis","volume":"91","author":"Zhang","year":"2021","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism, Biochimica et biophysica acta","volume":"1865","author":"Li","year":"2019","journal-title":"Mol. Basis Disease"},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0210","doi-asserted-by":"crossref","first-page":"114","DOI":"10.17691\/stm2020.12.5.13","article-title":"Bile Acids as a New Type of Steroid Hormones Regulating Nonspecific Energy Expenditure of the Body (Review)","volume":"12","author":"Zagoskin","year":"2021","journal-title":"Sovremennye Tehnologii v Medicine"},{"issue":"5","key":"10.1016\/j.bcp.2025.117200_b0215","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/bph.14126","article-title":"Effects of corilagin on alleviating cholestasis via farnesoid X receptor\u2010associated pathways in vitro and in vivo","volume":"175","author":"Yang","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"32","key":"10.1016\/j.bcp.2025.117200_b0220","doi-asserted-by":"crossref","first-page":"12535","DOI":"10.1074\/jbc.RA118.004188","article-title":"Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR","volume":"293","author":"Zheng","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.117200_b0225","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/164_2019_231","article-title":"Targeting FXR in Cholestasis","author":"Keitel","year":"2019","journal-title":"Bile Acids and Their Receptors"},{"issue":"8","key":"10.1016\/j.bcp.2025.117200_b0230","first-page":"724","article-title":"Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies","volume":"22","author":"Chen","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"11","key":"10.1016\/j.bcp.2025.117200_b0235","first-page":"965","article-title":"Dual-function natural products: Farnesoid X receptor agonist\/inflammation inhibitor for metabolic dysfunction-associated steatotic liver disease therapy","volume":"22","author":"Wang","year":"2024","journal-title":"Chin. J. Nat. Med."},{"issue":"19","key":"10.1016\/j.bcp.2025.117200_b0240","doi-asserted-by":"crossref","first-page":"13850","DOI":"10.1074\/jbc.M112.443937","article-title":"SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes","volume":"288","author":"Balasubramaniyan","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2025.117200_b0245","doi-asserted-by":"crossref","first-page":"184","DOI":"10.15252\/embj.201489527","article-title":"A dysregulated acetyl\/SUMO switch of FXR promotes hepatic inflammation in obesity","volume":"34","author":"Kim","year":"2014","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2025.117200_b0250","doi-asserted-by":"crossref","unstructured":"R. Gineste, A. Sirvent, R.j. Paumelle, S.p. Helleboid, A. Aquilina, R.l. Darteil, D.W. Hum, J.-C. Fruchart, B. Staels, Phosphorylation of Farnesoid X Receptor by Protein Kinase C Promotes Its Transcriptional Activity, Molecular Endocrinology 22(11) (2008) 2433-2447, doi: 10.1210\/me.2008-0092.","DOI":"10.1210\/me.2008-0092"},{"issue":"6","key":"10.1016\/j.bcp.2025.117200_b0255","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1002\/hep.22431","article-title":"The membrane protein ATPase class I type 8B member 1 signals through protein kinase C zeta to activate the farnesoid X receptor","volume":"48","author":"Frankenberg","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.bcp.2025.117200_b0260","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.apsb.2022.08.019","article-title":"SIRT1 activation synergizes with FXR agonism in hepatoprotection via governing nucleocytoplasmic shuttling and degradation of FXR","volume":"13","author":"Cui","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2019.05.009","article-title":"TRB3 stimulates SIRT1 degradation and induces insulin resistance by lipotoxicity via COP1","volume":"382","author":"Ren","year":"2019","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2025.117200_b0270","article-title":"CHK1 attenuates cardiac dysfunction via suppressing SIRT1-ubiquitination","volume":"162","author":"Yang","year":"2025","journal-title":"Metab. Clin. Experim."},{"issue":"2","key":"10.1016\/j.bcp.2025.117200_b0275","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1080\/15548627.2020.1860541","article-title":"SIRT1 - a new mammalian substrate of nuclear autophagy","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"issue":"3","key":"10.1016\/j.bcp.2025.117200_b0280","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1096\/fj.10-170597","article-title":"Suppressor of cytokine signaling 1 (SOCS1) limits NF\u03baB signaling by decreasing p65 stability within the cell nucleus","volume":"25","author":"Strebovsky","year":"2010","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2025.117200_b0285","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13058-023-01628-1","article-title":"Cooperative NF-\u03baB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer","volume":"25","author":"Duran","year":"2023","journal-title":"Breast Cancer Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225004654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:00:31Z","timestamp":1777377631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225004654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S0006295225004654"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117200","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nodosin alleviates cholestatic liver injury by activation of SIRT1\/FXR signaling pathway and inhibition of hepatic inflammation","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117200","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117200"}}